Paroxetine
Product Images NDC 63629-9499

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Paroxetine (NDC 63629-9499). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl636299499)

The label for Paroxetine Extended-Release Tablets, USP, 25 mg, from Bryant Ranch Prepack features the NDC number 63629-9499-01. It indicates the product is an extended-release, enteric-coated tablet with 30 tablets per package. The label includes storage instructions and cautions for pharmacists and patients, along with the BRP Pharmaceuticals logo.*

FDA Label Image

Chemical Structure (Paroxetine 01)

Chemical structure diagram of paroxetine hydrochloride, showing its molecular arrangement including a fluorophenyl group, piperidine ring, and methylenedioxy phenyl group, with associated hydrochloride ion.*

FDA Label Image

Figure 1 (Paroxetine 02)

A forest plot chart showing the fold change and 90% confidence intervals in pharmacokinetic parameters (Cmax and AUC) for various interacting drugs including Pimozide 2 mg, Desipramine 100 mg, Propranolol 80 mg twice daily, Digoxin 0.25 mg once daily, and Phenytoin 300 mg. The x-axis represents change relative to reference on a logarithmic scale from 0.1 to 10.0.*

FDA Label Image

Figure 2 (Paroxetine 03)

A forest plot displaying fold change and 90% confidence intervals for Cmax and AUC pharmacokinetic parameters of paroxetine when coadministered with different interacting drugs, including cimetidine 300 mg three times daily, phenobarbital 100 mg once daily, phenytoin 300 mg once daily, digoxin 0.25 mg once daily, and diazepam 5 mg three times daily. The x-axis shows change relative to reference from 0 to 2.*

FDA Label Image

Figure 3 (Paroxetine 04)

A scatter plot chart showing fold change and 90% confidence intervals for pharmacokinetic parameters (Cmax, AUC, Cmin) in different populations and conditions, including renal impairment (mild, moderate, severe), hepatic impairment, age over 65 years at various doses, and gender (males). The x-axis depicts change relative to reference on a logarithmic scale from 0.5 to 50.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.